Cresco Labs (OTCMKTS:CRLBF – Free Report) had its price objective upped by Wedbush from $2.50 to $3.00 in a research note released on Thursday, Benzinga reports. The brokerage currently has an outperform rating on the stock. A number of other equities research analysts have also recently issued reports on the stock. Echelon Wealth Partners upgraded […]